Home › Funds › Davis New York Venture Fund
Fund family: DAVIS NEW YORK VENTURE FUND INC · Filed by DAVIS NEW YORK VENTURE FUND INC (CIK 71701) · SEC series S000003439
Share classes and tickers: DNVYX (C000009519), NYVBX (C000009517), NYVCX (C000009518), NYVRX (C000009520), NYVTX (C000009516)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 555 with, 37 against, 0 abstentions (not counted as with management). Shareholder proposals: 4 FOR, 33 AGAINST, 0 abstained, by the filing’s own vote-source field.
Each ballot item this fund voted is set against the votes of the other DAVIS NEW YORK VENTURE FUND INC funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most DAVIS NEW YORK VENTURE FUND INC funds on all 133 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 66.2% of this fund’s 592 such votes could be given a sector; the other 200 (33.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 116 | 10 | 8.6% |
| Health Care | 77 | 3 | 3.9% |
| Technology | 55 | 10 | 18.2% |
| Consumer Discretionary | 42 | 4 | 9.5% |
| Consumer Staples | 38 | 4 | 10.5% |
| Energy | 32 | 1 | 3.1% |
| Industrials | 32 | 1 | 3.1% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 366 | 0 |
| Corporate Governance | 59 | 18 |
| Compensation | 41 | 2 |
| Audit-related | 39 | 0 |
| Capital Structure | 35 | 0 |
| Say-on-Pay | 27 | 0 |
| Environment or Climate | 9 | 9 |
| Extraordinary Transactions | 9 | 0 |
| Other Social Issues | 5 | 5 |
| Human Rights or Human Capital/workforce | 2 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Meta Platforms, Inc. | May 27, 2026 | $597M | 22 | 9 |
| Capital One Financial Corporation | May 8, 2026 | $454M | 16 | 1 |
| Applied Materials, Inc. | March 12, 2026 | $447M | 12 | 0 |
| Viatris Inc. | May 15, 2026 | $422M | 15 | 0 |
| Viatris Inc. | December 5, 2025 | $422M | 15 | 0 |
| U.S. Bancorp | April 21, 2026 | $393M | 14 | 0 |
| Devon Energy Corporation | June 30, 2026 | $342M | 13 | 0 |
| CVS Health Corporation | May 14, 2026 | $339M | 17 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 8, 2026 | Capital One Financial Corporation | Stockholder proposal to require a shareholder vote on golden parachute arrangements. Shareholder proposal | Against | For |
| May 14, 2026 | CVS Health Corporation | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | Against | For |
| April 16, 2026 | Texas Instruments Incorporated | Stockholder proposal to permit stockholders to act by written consent. Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| February 5, 2026 | Tyson Foods, Inc. | Shareholder proposal regarding disclosure of voting results based on class of shares. Shareholder proposal | For | Against |
| February 5, 2026 | Tyson Foods, Inc. | Shareholder proposal regarding report on environmental and human health impacts from waste lagoons. Shareholder proposal | Against | For |
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | Against | For |
| May 20, 2026 | Markel Group Inc. | Shareholder proposal for a report on the Company's strategies and action plans to mitigate material environmental risks. Shareholder proposal | Against | For |
| May 20, 2026 | Markel Group Inc. | Shareholder proposal to give shareholders an ability to call for a special shareholder meeting. Shareholder proposal | Against | For |
594 ballot items at 43 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Davis New York Venture Fund (DNVYX) voted at 43 shareholder meetings of 38 companies, on 594 ballot items in all. Where management made a recommendation, the fund followed it on 93.8% of the items and voted against it 37 times. Its most frequent area of disagreement was corporate governance (18 of its votes against management). It voted on 37 shareholder proposals. It voted the same way as most DAVIS NEW YORK VENTURE FUND INC funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.